Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.003
Sell
RSI(14)
38.753
Neutral
STOCH(KDJ)(9,3,3)
37.102
Buy
ATR(14)
0.056
High Vlolatility
CCI(14)
-47.956
Neutral
Williams %R
70.227
Sell
TRIX(12,20)
-1.012
Sell
StochRSI(14)
87.572
Overbought
Search
Fibrobiologics Inc
FBLGAdd to Watchlist
0.700USD
-0.019-2.67%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.46MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-2.67%
5 Days
-1.69%
1 Month
-26.14%
6 Months
-89.45%
Year to Date
-84.44%
1 Year
-94.51%
Key Figures
0.739Open
0.739High
111.55KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
3.18%Turnover Ratio
0.719Prev. Close
0.680Low
62.35KTurnover
LossP/E Static
0.95P/B
0.00%Div Yield TTM
-215.16%ROA
19.80052wk High
1.13Volume Ratio
-11.16MNet Profit
3.51MShares
-6.9672EPS TTM
--Beta
-754.75%ROE
0.95252wk Low
8.19%Amplitude
--Gross Margin
2.46MMarket Cap
-2.44Reward/Risk
7.31%Risk Rate
Fibrobiologics Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
1
analysts
Buy
Current Rating
13.500
Target Price
+1962.33%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Fibrobiologics Inc
FBLG
1
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
0.670
Buy
MA10
0.709
Sell
MA20
0.781
Sell
MA50
0.881
Sell
MA100
1.711
Sell
MA200
4.062
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Fibrobiologics Inc Info
FibroBiologics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis and certain cancers, and potential human longevity applications including thymic involution reversal. Its product candidates include CybroCell, CYMS101 and CYWC628. CybroCell is an allogeneic fibroblast cell-based therapy for degenerative disc disease. This technology is being designed as an alternative method for repairing the cartilage of the intervertebral disc (or any other articular cartilage). It is developing CYMS101 as an allogeneic fibroblast cell-based therapy to treat multiple sclerosis (MS) and has completed the Phase I study. It is developing CYWC628 as an allogeneic fibroblast cell-based therapy for wound healing. Its CYPS317 is used for the treatment of Psoriasis.
Ticker SymbolFBLG
CompanyFibrobiologics Inc
CEOO'Heeron (Pete)
Websitehttps://fibrobiologics.com/
Shareholders
Related Instruments
-0.53%
+0.23%
-1.00%
-2.54%
+0.33%
-1.44%
-0.61%
-0.79%
-8.78%
+0.48%
+0.70%
-1.00%
-0.69%
+0.49%
-1.08%
+3.32%
0.00%
+1.34%
-0.87%
-2.17%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Fibrobiologics Inc (FBLG)?
The current price of Fibrobiologics Inc (FBLG) is 0.70.
What is the symbol of Fibrobiologics Inc?
The ticker symbol of Fibrobiologics Inc is FBLG.
What is the 52-week high of Fibrobiologics Inc?
The 52-week high of Fibrobiologics Inc is 19.80.
What is the 52-week low of Fibrobiologics Inc?
The 52-week low of Fibrobiologics Inc is 0.95.
What is the market capitalization of Fibrobiologics Inc?
The market capitalization of Fibrobiologics Inc is 2.46M.
Is Fibrobiologics Inc (FBLG) currently rated as Buy, Hold, or Sell?
According to analysts, Fibrobiologics Inc (FBLG) has an overall rating of Buy, with a price target of 13.50.
What is the Earnings Per Share (EPS TTM) of Fibrobiologics Inc (FBLG)?
The Earnings Per Share (EPS TTM) of Fibrobiologics Inc (FBLG) is -8.35.